Trials
Search / Trial NCT06440226

Testing Methods to Increase the Frequency of Lucid Dreaming

Launched by ABDULRAHEEM MOHAMED GOUDA · May 28, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Completed

Keywords

Sleep Sleep Disorder Lucid Dreaming Dreams Sleep Hygiene

ClinConnect Summary

This detailed study explores the profound impact of lucid dreaming on individuals and assesses various techniques designed to intentionally induce lucid dreams. Lucid dreaming, where dreamers are aware that they are dreaming and can often control their dreams' content, has long intrigued both the scientific community and the general public due to its potential for deep psychological insight and self-improvement.

The primary objective of the research was to investigate methods that could significantly increase the likelihood of inducing lucid dreams.

In continuation, the study explores var...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Normal blood pressure, Healthy weight, no record of sleep apnea, no difficulty sleeping, ages between 18-30 only.
  • Exclusion Criteria:
  • • Overweight(muscle being taken into consideration, not using BMI), high or low blood pressure,

Trial Officials

Abdelraheem Mohamed

Study Chair

Reserology Research Foundation

About Abdulraheem Mohamed Gouda

Abdulraheem Mohamed Gouda is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical study design and implementation, he focuses on innovative therapeutic solutions across various therapeutic areas. His expertise in regulatory compliance and patient safety ensures that all trials adhere to the highest ethical standards. Passionate about fostering collaboration among stakeholders, Abdulraheem strives to accelerate the development of effective treatments while prioritizing the needs of participants and the integrity of the research process.

Locations

London, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0